Human Phenotype Ontology 
Grandparent Node:
expand
Abnormal blood ion concentration (HP:0003111)help
Parent Node:
expand
Abnormal blood phosphate concentration (HP:0100529)help
..Starting node
..expand
Hyperphosphatemia (HP:0002905)help
Term ID: 2905
Name: Hyperphosphatemia
Synonym: High blood phosphate levels
Definition: An abnormally increased phosphate concentration in the blood.
Comments:
Reference: HP:0002905
Genes and Diseases:
 
       Child Nodes:

 Sister Nodes: 
..expandElevated plasma pyrophosphate (HP:0011864) help
..expandHypophosphatemia (HP:0002148) help
..expandobsolete Increased urine O-phosphoethanolamine level (HP:0410158) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002905HP:0002905Hyperphosphatemia0CACNA1S CL E G H7791397ORPHA:423Malignant hyperthermia of anesthesiaHP:0040282 - Frequent247
HP:0002905HP:0002905Hyperphosphatemia0CASR CL E G H8461514ORPHA:428Autosomal dominant hypocalcemiaHP:0040282 - Frequent272
HP:0002905HP:0002905Hyperphosphatemia0CASR CL E G H8461514OMIM:601198Hypocalcemia, autosomal dominant 1272
HP:0002905HP:0002905Hyperphosphatemia0COX1 CL E G H45127419ORPHA:99845Genetic recurrent myoglobinuria
HP:0002905HP:0002905Hyperphosphatemia0COX3 CL E G H45147422ORPHA:99845Genetic recurrent myoglobinuria
HP:0002905HP:0002905Hyperphosphatemia0FAM111A CL E G H6390124725ORPHA:93325Autosomal dominant Kenny-Caffey syndromeHP:0040282 - Frequent8
HP:0002905HP:0002905Hyperphosphatemia0FAM111A CL E G H6390124725OMIM:127000Kenny-caffey syndrome, type 2.8
HP:0002905HP:0002905Hyperphosphatemia0GALNT3 CL E G H25914125OMIM:211900Tumoral calcinosis, hyperphosphatemic, familial, 1.46
HP:0002905HP:0002905Hyperphosphatemia0GCM2 CL E G H92474198ORPHA:2239Familial isolated hypoparathyroidism due to agenesis of parathyroid glandHP:0040281 - Very frequent51
HP:0002905HP:0002905Hyperphosphatemia0GCM2 CL E G H92474198OMIM:618883HYPOPARATHYROIDISM, FAMILIAL ISOLATED, 2; FIH251
HP:0002905HP:0002905Hyperphosphatemia0GNA11 CL E G H27674379ORPHA:428Autosomal dominant hypocalcemiaHP:0040282 - Frequent16
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392ORPHA:79443Pseudohypoparathyroidism type 1AHP:0040281 - Very frequent101
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392ORPHA:94089Pseudohypoparathyroidism type 1BHP:0040281 - Very frequent101
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392ORPHA:79444Pseudohypoparathyroidism type 1CHP:0040281 - Very frequent101
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392OMIM:103580Pseudohypoparathyroidism, type IA.101
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392OMIM:603233Pseudohypoparathyroidism, type IB.101
HP:0002905HP:0002905Hyperphosphatemia0GNAS CL E G H27784392OMIM:612462Pseudohypoparathyroidism, type IC.101
HP:0002905HP:0002905Hyperphosphatemia0GNAS-AS1 CL E G H14977524872OMIM:603233Pseudohypoparathyroidism, type IB.1
HP:0002905HP:0002905Hyperphosphatemia0KL CL E G H93656344OMIM:617994TUMORAL CALCINOSIS, HYPERPHOSPHATEMIC, FAMILIAL, 3; HFTC368
HP:0002905HP:0002905Hyperphosphatemia0LPIN1 CL E G H2317513345ORPHA:99845Genetic recurrent myoglobinuria95
HP:0002905HP:0002905Hyperphosphatemia0PDE4D CL E G H51448783ORPHA:280651Acrodysostosis with multiple hormone resistanceHP:0040281 - Very frequent113
HP:0002905HP:0002905Hyperphosphatemia0PGAP2 CL E G H2731517893OMIM:614207Hyperphosphatasia with mental retardation syndrome 3.8
HP:0002905HP:0002905Hyperphosphatemia0PRKAR1A CL E G H55739388OMIM:101800Acrodysostosis 1, with or without hormone resistance134
HP:0002905HP:0002905Hyperphosphatemia0PRKAR1A CL E G H55739388ORPHA:280651Acrodysostosis with multiple hormone resistanceHP:0040281 - Very frequent134
HP:0002905HP:0002905Hyperphosphatemia0PTH CL E G H57419606OMIM:146200Hypoparathyroidism, familial isolated.16
HP:0002905HP:0002905Hyperphosphatemia0RYR1 CL E G H626110483ORPHA:466650Exercise-induced malignant hyperthermiaHP:0040283 - Occasional1200
HP:0002905HP:0002905Hyperphosphatemia0RYR1 CL E G H626110483ORPHA:423Malignant hyperthermia of anesthesiaHP:0040282 - Frequent1200
HP:0002905HP:0002905Hyperphosphatemia0RYR1 CL E G H626110483OMIM:145600Malignant hyperthermia, susceptibility to, 1.1200
HP:0002905HP:0002905Hyperphosphatemia0STX16 CL E G H867511431ORPHA:94089Pseudohypoparathyroidism type 1BHP:0040281 - Very frequent86
HP:0002905HP:0002905Hyperphosphatemia0STX16 CL E G H867511431OMIM:603233Pseudohypoparathyroidism, type IB.86
HP:0002905HP:0002905Hyperphosphatemia0TBCE CL E G H690511582OMIM:241410Hypoparathyroidism-Retardation-Dysmorphism syndrome.52
HP:0002905HP:0002905Hyperphosphatemia0TBCE CL E G H690511582ORPHA:2323Sanjad-Sakati syndromeHP:0040281 - Very frequent52
HP:0002905HP:0002905Hyperphosphatemia0TNFRSF11B CL E G H498211909OMIM:239000Paget disease of bone 5, juvenile-onset.44


Genes (20) :CACNA1S CASR COX1 COX3 FAM111A GALNT3 GCM2 GNA11 GNAS GNAS-AS1 KL LPIN1 PDE4D PGAP2 PRKAR1A PTH RYR1 STX16 TBCE TNFRSF11B

Diseases (25) :ORPHA:423 ORPHA:428 OMIM:601198 ORPHA:99845 ORPHA:93325 OMIM:127000 OMIM:211900 ORPHA:2239 OMIM:618883 ORPHA:79443 ORPHA:94089 ORPHA:79444 OMIM:103580 OMIM:603233 OMIM:612462 OMIM:617994 ORPHA:280651 OMIM:614207 OMIM:101800 OMIM:146200 ORPHA:466650 OMIM:145600 OMIM:241410 ORPHA:2323 OMIM:239000
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.